Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients

Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients

A randomized, multicenter, double-blind, parallel-group study was conducted in order to evaluate the hormonal kinetics, pharmacokinetics, efficacy and safety of TAP-144-SR (3M) a three-month sustained-release injectable preparation of leuprorelin acetate, a highly active luteinizing hormone-releasin...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 48(2002), 12 vom: 28. Dez., Seite 781-95
1. Verfasser: Koiso, Kenkichi (VerfasserIn)
Weitere Verfasser: Akaza, Hideyuki, Naito, Seiji, Usami, Michiyuki, Tsukamoto, Taiji, Shimazaki, Jun, Kotake, Toshihiko, Yamanaka, Hidetoshi, Oohashi, Yasuo, Yoshinaka, Ryoji, Onouchi, Hitoshi, Yokokawa, Kiyoshi
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2002
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Comparative Study English Abstract Journal Article Multicenter Study Randomized Controlled Trial Antineoplastic Agents, Hormonal Delayed-Action Preparations Gonadotropin-Releasing Hormone 33515-09-2 mehr... Testosterone 3XMK78S47O Leuprolide EFY6W0M8TG